- Home
- CTRE vs AXSM Comparison
CTRE vs AXSM Comparison
Compare CTRE & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CTRE | AXSM |
|---|---|---|
| Founded | 2013 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.6B | 7.3B |
| IPO Year | 2013 | 2015 |
Fundamental Metrics
Financial Performance| Metric | CTRE | AXSM |
|---|---|---|
| Price | $38.12 | $132.94 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 14 | 22 |
| Target Price | $43.64 | ★ $271.05 |
| AVG Volume (30 Days) | ★ 2.3M | 1.1M |
| Earning Date | 11-05-2026 | 11-02-2026 |
| Dividend Yield | ★ 4.20% | N/A |
| EPS Growth | ★ 96.25 | 38.56 |
| EPS | ★ 1.08 | N/A |
| Revenue | ★ $476,393,000.00 | N/A |
| Revenue This Year | $31.71 | $49.41 |
| Revenue Next Year | $31.27 | $52.53 |
| P/E Ratio | $51.28 | ★ N/A |
| Revenue Growth | ★ 60.79 | N/A |
| 52 Week Low | $34.74 | $123.00 |
| 52 Week High | $43.62 | $260.19 |
Technical Indicators
Market Signals| Indicator | CTRE | AXSM |
|---|---|---|
| Relative Strength Index (RSI) | 57.84 | 26.41 |
| Support Level | $35.64 | N/A |
| Resistance Level | $40.34 | $225.16 |
| Average True Range (ATR) | 0.93 | 7.32 |
| MACD | 0.25 | -0.06 |
| Stochastic Oscillator | 88.55 | 24.38 |
Price Performance
Historical ComparisonAbout CTRE CareTrust REIT Inc.
CareTrust REIT Inc is a self-administered, publicly traded REIT engaged in the ownership, acquisition, financing, development, and leasing of skilled nursing, seniors housing, and other healthcare-related properties. The company has one reportable segment consisting of investments in healthcare-related real estate assets. It generates revenues by leasing healthcare-related properties to healthcare operators under triple-net lease arrangements, in which the tenant is solely responsible for property-related costs. The company operates in Domestic and Foreign markets, with the majority of revenue coming from Domestic operations.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.